Reversal of Type 2 Diabetes in a Patient With Hashimoto's Thyroiditis Through Combined Pharmacologic and Lifestyle Intervention
Abstract
Type 2 diabetes mellitus (T2DM) is typically considered a progressive condition, but recent evidence suggests potential reversibility through structured lifestyle intervention. We report the case of a 32-year-old Egyptian female with Hashimoto's thyroiditis and newly diagnosed T2DM, confirmed by elevated fasting blood glucose and HbA1c levels. The patient was managed with once-daily metformin, continued levothyroxine, a 500-calorie daily energy deficit, and progressive resistance training three times per week. After 12 months, fasting glucose and HbA1c values decreased below the diagnostic thresholds for diabetes, allowing metformin to be discontinued. Follow-up at one, three, and six months post-intervention confirmed sustained biochemical remission. This case highlights the potential for reversing diabetes in select patients through a combined pharmacological and lifestyle approach.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.